Forum Home Page [see Broadridge note below]

 The Shareholder ForumTM`

Fair Investor Access

This public program was initiated in collaboration with The Conference Board Task Force on Corporate/Investor Engagement and with Thomson Reuters support of communication technologies. The Forum is providing continuing reports of the issues that concern this program's participants, as summarized  in the January 5, 2015 Forum Report of Conclusions.

"Fair Access" Home Page

"Fair Access" Program Reference

 

Related Projects 2012-2019

For graphed analyses of company and related industry returns, see

Returns on Corporate Capital

See also analyses of

Shareholder Support Rankings

 
 
 

Forum distribution:

Activist disputes professor's analysis of performance

 

The article and video below report a controversy about an example of activist performance cited by Professor Jeffrey Sonnenfeld of the Yale School of Management in an opinion published April 1, 2015 in The Wall Street Journal: "Activist Shareholders, Sluggish Performance." The dispute was initiated by Nelson Peltz of Trian Fund Management in the following April 2, 2015 morning video interview (which is no longer available on the CNBC website, but was accessible in the NBC archive as of April 4, 2015), in relation to which Trian subsequently filed an April 3, 2015 4:31pm SEC Schedule 14A report to correct Mr. Peltz' erroneous overstatement of his flagship fund's performance.

Visit NBCNews.com for breaking news, world news, and news about the economy

Professor Sonnenfeld has asked the Forum to present his following response to the issues raised by Mr. Peltz (emphasis in original):

1)  The key question is: why does it have to be only HIM as the suitable rep on board and not candidates like Ed Breen, James  Gallogly, etc. whom he’d desired previously?

2)  The key performance data is that 5 of 11 firms underperform the S&P when he joins the board. If Trian/his personal board PRESENCE (not investment history) are so key to tie up this company with the expensive proxy battle, what has company performance been like when he joins boards?  Mr. Peltz wants to look at his investment history but the entire conflict is over his insistence on his board service not how he chooses to invest!

However, it should be noted that, even so, Trian’s total shareholder returns from 2012 through 2014, even using the cumulative returns he prefers, were 54% vs the S&P 500 at 74.6%.  All this data is from public third party sources. One of Trian’s main arguments in the DuPont fight is that its Board needs Trian to drive better returns, but the realities of the data show that that the record doesn’t support his position.

3)  The unaddressed history is:  What happened in Mr. Peltz’ prior chemical industry board experience about which he is so proud?  What is the story with joining the Chemtura board for several years and then quitting a week before they file for bankruptcy?

4)  The major lesson is:  You generally do better investing in the S&P 500 index funds, or better yet in the companies activists target, than to invest in the activists’ hedge funds.

5)   Some activists can dish it out but they can’t take the same scrutiny they put on others.

Note: Professor Sonnenfeld has also emphasized that he is “not a paid advisor to DuPont or its CEO Ellen Kullman and that [his] Yale programs receive no support from Kullman or DuPont.”

 

Source: CNBC, April 2, 2015 article and video

 

Business


 

Peltz vs Sonnenfeld over activist fund performance

Matthew J. Belvedere | @Matt_Belvedere

Thursday, 2 Apr 2015 | 4:06 PM ET CNBC.com


Activists push back

Thursday, 2 Apr 2015 | 7:21 AM ET 

CNBC's Scott Wapner reads a statement from Nelson Peltz and Trian Partners, defending their performance. And Jeff Sonnenfeld, Yale School of Management, defends his critical comments.

Management expert Jeffrey Sonnenfeld is going after activists investors—saying Thursday ordinary investors would do better putting their money into the stocks of the target companies than the investment firms on the attack.

Activists "should be held to the same accountability that their target firms are under," the Yale School of Management senior associate dean told CNBC—echoing a position he took in a Wall Street Journal op-ed.

In a "Squawk Box" interview, Sonnenfeld singled out Nelson Peltz's Trian Fund: "Last year ... Trian came in at 8.8 percent return. The S&P was 13.7 percent."

"That's just the facts," he said.

Trian defended itself in a statement to CNBC:

"Mr. Sonnenfeld has twisted and cherry-picked the data to present a highly misleading and inaccurate picture of Trian's performance. The fact is that Trian has delivered excellent results for our investors, which is why we have $12 billion in AUM [assets under management]. Our flagship fund has generated a 137 percent return net of fees since inception in November 2005, outpacing the S&P 500 by 2,900 bps [basis points]. And if you look at our core positions from the day we invested until today, we have outperformed the S&P 500 by an average of 764 bps annually. That outperformance increases to 879 bps for companies on which Nelson Peltz served on the board."

Sonnenfeld responded to Trian's statement, insisting that Trian is "underperforming their own target companies" such as DuPont, the chemcial company locked in a proxy war with Peltz.

"If you put $100 in DuPont when Ellen Kullman became CEO [in 2009], that would be worth $240 today," according to Sonnenfeld's calculations.

"If you put it into the S&P 500, it would be about $200," he continued. "If you put it into Trian, it would be worth $190."

Trian has proposed adding Peltz and another nominee to DuPont's board as well as two other nominees to the board of a unit DuPont plans to spin off.

DuPont is planning to spin off its performance chemicals business, but Peltz wants the company to separate its nutrition and health, agriculture and industrial biosciences divisions from its volatile but cash flow-strong materials businesses.

DuPont has rejected the proposal, stressing that keeping its businesses together would allow the company to benefit from its science platform, global scale, market access and brand.

In a CNBC interview in March, Peltz said breaking up the company would be "the most efficient way" to get rid of $2 billion to $4 billion in costs.

The company's shares have risen nearly 9 percent since Trian went public with its break-up proposal in September.

"This is a huge sea change. If we were having this discussion ... 25 years ago we have many of the same people [like Peltz]. They were called sharks, raiders ... at that time," Sonnenfeld argued.

 

 

© 2015 CNBC LLC. All Rights Reserved.

A Division of NBCUniversal

 

This Forum program was open, free of charge, to anyone concerned with investor interests in the development of marketplace standards for expanded access to information for securities valuation and shareholder voting decisions. As stated in the posted Conditions of Participation, the purpose of this public Forum's program was to provide decision-makers with access to information and a free exchange of views on the issues presented in the program's Forum Summary. Each participant was expected to make independent use of information obtained through the Forum, subject to the privacy rights of other participants.  It is a Forum rule that participants will not be identified or quoted without their explicit permission.

This Forum program was initiated in 2012 in collaboration with The Conference Board and with Thomson Reuters support of communication technologies to address issues and objectives defined by participants in the 2010 "E-Meetings" program relevant to broad public interests in marketplace practices. The website is being maintained to provide continuing reports of the issues addressed in the program, as summarized in the January 5, 2015 Forum Report of Conclusions.

Inquiries about this Forum program and requests to be included in its distribution list may be addressed to access@shareholderforum.com.

The information provided to Forum participants is intended for their private reference, and permission has not been granted for the republishing of any copyrighted material. The material presented on this web site is the responsibility of Gary Lutin, as chairman of the Shareholder Forum.

Shareholder Forum™ is a trademark owned by The Shareholder Forum, Inc., for the programs conducted since 1999 to support investor access to decision-making information. It should be noted that we have no responsibility for the services that Broadridge Financial Solutions, Inc., introduced for review in the Forum's 2010 "E-Meetings" program and has since been offering with the “Shareholder Forum” name, and we have asked Broadridge to use a different name that does not suggest our support or endorsement.